Meta-Analysis
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jul 28, 2014; 20(28): 9611-9617
Published online Jul 28, 2014. doi: 10.3748/wjg.v20.i28.9611
Table 1 Development of adenocarcinoma
Ref.Number of patientsIncidence of adenocarcinoma (n/yr follow-up)Annual incidence of adenocarcinoma (95%CI)1Number of cancers expected to develop (95%CI)Individual’s lifetime risk of adenocarcinoma (95%CI)
Desai et al[5]11434186/585470.32% (0.27-0.37)557 (479-643)0.071 (0.061-0.082)
Yousef et al[6]11279209/474960.44% (0.38-0.50)771 (670-883)0.098 (0.085-0.112)
Sikkema et al[7]14109344/618040.56% (0.50-0.62)975 (874-1084)0.124 (0.111-0.138)
Thomas et al[8]9469186/366350.51% (0.44-0.59)890 (766-1027)0.113 (0.097-0.130)
Gatenby et al[3]80723/39120.59% (0.38-0.87)1030 (653-1546)0.131 (0.083-0.196)